BioFactura and CuraTeQ Enter Exclusive License Agreement to Commercialize Biosimilar for Stelara

Published on : Published by : BioBuzz Media

BioFactura and CuraTeQ Enter Exclusive License Agreement to Commercialize Biosimilar for Stelara July 10, 2023 BioFactura, Inc. and CuraTeQ Biologics Private Limited, a subsidiary of Aurobindo Pharma Limited, have signed [….]

Texcell Unveils State-of-the-Art Viral Clearance Testing Facility

Published on : Published by : BioBuzz Media

Texcell is pleased to announce the opening of their newest testing facility in North America, representing a significant milestone in Texcell’s commitment to advancing the viral safety of biotherapeutics and medical devices. Designed to support simultaneous viral clearance and biosafety studies, this 27,000 sq ft facility is built with a modular design that enhances the flexibility required in today’s contract testing environment. Texcell – North America’s dedicated teams are ready to support biosafety studies for monoclonal antibodies, gene therapies, and medical devices coming to the market.

5 Questions With Sandy Applebee, Associate Director, Marketing and Communications at The Geneva Foundation

Published on : Published by : BioBuzz Media

Sandy Applebee is an accomplished communications and public affairs professional with more than 20 years of experience in the industry, and five years in the scientific field. She has worked for a variety of industries, from biotechnology to economic development in local government, and government contracting. A veteran Army Broadcast Journalist, Sandy is the Associate Director of Marketing & Communications at The Geneva Foundation, a 501(c)3 advancing military medicine worldwide through research, development, and education.